Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mineralocorticoid Receptor Antagonist”

74 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 74 results

Testing effectiveness (Phase 2)Looking for participantsNCT07029503
What this trial is testing

Swedish Cardiac And Renal Failure Study-1

Who this might be right for
HFrEF - Heart Failure With Reduced Ejection FractionChronic Kidney Disease
Karolinska Institutet 40
Not applicableStudy completedNCT04903717
What this trial is testing

Pragmatic Trial Of Alerts for Use of Mineralocorticoid Receptor Antagonists

Who this might be right for
Heart Failure With Reduced Ejection Fraction
Yale University 1,210
Testing effectiveness (Phase 2)Study completedNCT02497300
What this trial is testing

Vascular Effects of Mineralocorticoid Receptor Antagonism in Kidney Disease

Who this might be right for
Chronic Kidney DiseaseAlbuminuria
University of Alabama at Birmingham 21
Post-approval studies (Phase 4)Study completedNCT01837108
What this trial is testing

Eplerenone and Extracellular Adenosine Formation

Who this might be right for
Pharmacodynamics
Radboud University Medical Center 14
Not applicableNot Yet RecruitingNCT07775482
What this trial is testing

Finerenone for AKI: a Multicenter, Randomized, Placebo-Controlled Feasibility Pilot Trial

Who this might be right for
Acute Kidney InjuryRenal Insufficiency,ChronicKidney Diseases
Jean-Maxime Côté 72
Post-approval studies (Phase 4)Looking for participantsNCT06727409
What this trial is testing

Use of Clinical-trials and Simulation Models to Estimate Cost-effectiveness of Non-steroidal Mineralocorticoid Antagonists, RASi and SGLT2i as Triple Therapy With Type 2 Diabetes and Chronic Kidney Disease

Who this might be right for
Patients With Type 2 Diabetes
Chinese University of Hong Kong 82
Not applicableStudy completedNCT02848170
What this trial is testing

Study of CS-3150 Compared to Olmesartan in Patients With Essential Hypertension

Who this might be right for
Essential Hypertension
Daiichi Sankyo Co., Ltd. 40
Large-scale testing (Phase 3)Study completedNCT02585843
What this trial is testing

Mineralocorticoid Receptor Antagonists (MRA) in Heart Failure (HF) and Loop Diuretic Resistance

Who this might be right for
Heart Failure
Columbia University 20
Post-approval studies (Phase 4)UnknownNCT01510795
What this trial is testing

Mineralocorticoid Receptor Antagonist and Kidney Allograft Histology

Who this might be right for
Kidney Failure, Chronic
Clinical Hospital Merkur 40
Post-approval studies (Phase 4)Study completedNCT03683069
What this trial is testing

Mineralocorticoid Receptor (MR) Antagonist (Eplerenone) vs Amlodipine and STRIATIN

Who this might be right for
HypertensionGenetics Hypertension
Brigham and Women's Hospital 90
Not applicableStudy completedNCT03789357
What this trial is testing

Prevalence of Primary Aldosteronism in Patients With Stroke

Who this might be right for
Primary AldosteronismStroke
Changi General Hospital 300
Post-approval studies (Phase 4)Looking for participantsNCT06523465
What this trial is testing

Statin Combined with Amlodipine Treats Primary Aldosteronism

Who this might be right for
Primary AldosteronismStatinMineralocorticoid Receptor Antagonist+1 more
Third Military Medical University 180
Large-scale testing (Phase 3)Study completedNCT04435626
What this trial is testing

Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%

Who this might be right for
Heart Failure
Bayer 6,016
Large-scale testing (Phase 3)Study completedNCT02890173
What this trial is testing

Study of CS-3150 in Patients With Essential Hypertension

Who this might be right for
Essential Hypertension
Daiichi Sankyo Co., Ltd. 1,001
Post-approval studies (Phase 4)UnknownNCT05814770
What this trial is testing

Comparing the Efficacy and Safety of Finerenone and Spironolactone in the Treatment of Primary Aldosteronism

Who this might be right for
Primary AldosteronismHypertension
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 96
Not applicableStudy completedNCT01728493
What this trial is testing

Primary Aldosteronism in General Practice: Organ Damage, Epidemiology and Treatment

Who this might be right for
Primary AldosteronismPrimary Hyperaldosteronism
Radboud University Medical Center 700
Testing effectiveness (Phase 2)Looking for participantsNCT06655480
What this trial is testing

Triple Combination Therapy (ARNI, SGLT2i, MRA) in Advanced HFpEF

Who this might be right for
HFpEFLVDDMyocardial Fibrosis
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation 50
Large-scale testing (Phase 3)Study completedNCT02808026
What this trial is testing

Study of CS-3150 in Patients With Severe Hypertension

Who this might be right for
Severe Hypertension
Daiichi Sankyo Co., Ltd. 20
Post-approval studies (Phase 4)Looking for participantsNCT07026539
What this trial is testing

Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes.

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Chronic Kidney Disease Due to Type 2 Diabetes MellitusCardiovascular Diseases
University of Aarhus 80
Not applicableNot Yet RecruitingNCT06637618
What this trial is testing

Does the Sequence of Heart Failure Medication Matter

Who this might be right for
Heart Failure, Reduced Ejection Fraction
Aarhus University Hospital 16,000
Next Page